Position in IMVT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$52,978,750
-$12,522,467 QoQ
Shares Held
1,375,000
-47.9% QoQ
Ownership
0.666%
of shares outstanding
% of Portfolio
9.03%
of 13F equity value
Holder Rank
#21
of 224 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Alpine Global Management, LLC holds $66,598,591 across 8 Biotechnology names. IMVT ranks #1 (79.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
This page
|
1,375,000 | $52,978,750 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
32,500 | $4,313,725 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
6,033 | $3,239,419 | |
| 4 | TECH |
BIO-TECHNE Corp
|
40,000 | $2,826,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
33,339 | $2,717,461 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,467 | $441,611 | |
| 7 | ACHV |
Achieve Life Sciences, Inc.
|
12,500 | $81,625 | |
| 8 | NUVL |
Nuvalent, Inc.
|
1,643 | $0 |
All Filings in IMVT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,978,750 | 1,375,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $65,501,217 | 2,636,925 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $66,770,510 | 2,626,692 | Shares | Sole | 2026-02-26 | |
| 2025-09-30 | $44,406,263 | 2,754,731 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $42,027,072 | 2,626,692 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $44,890,166 | 2,626,692 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $53,476,052 | 2,158,904 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $53,675,891 | 1,882,704 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $50,363,385 | 1,907,704 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $60,830,166 | 1,882,704 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $58,913,412 | 1,398,372 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $48,082,476 | 1,252,474 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $27,308,149 | 1,439,544 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $22,327,327 | 1,439,544 | Shares | Sole | 2023-11-21 | |
| 2022-12-31 | $26,625,000 | 1,500,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $24,261,934 | 4,348,017 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,347,266 | 4,448,017 | Shares | Sole | 2022-11-03 | |
| 2022-03-31 | $21,278,457 | 3,861,789 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $25,619,640 | 3,007,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $26,071,738 | 3,000,200 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $21,140,000 | 2,000,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $17,595,527 | 1,096,978 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||